Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilaria Rivolta

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Epilepsia|September 25, 2023
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic dietJacopo C DiFrancesco, Francesca Ragona, Carmen Murano, et al.
International Journal of Cardiology|June 17, 2018
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe<sup>-/-</sup> atherosclerotic miceGabriele Romano, Serena Reggi, Barbara Kutryb-Zajac, et al.
Epilepsy Research|April 16, 2019
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literatureJacopo C DiFrancesco, Barbara Castellotti, Raffaella Milanesi, et al.
European Heart Journal|July 30, 2024
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implicationsAdriana Tarantino, Giuseppe Ciconte, Dario Melgari, et al.
European Heart Journal|November 22, 2020
Brugada syndrome genetics is associated with phenotype severityGiuseppe Ciconte, Michelle M Monasky, Vincenzo Santinelli, et al.
Ebiomedicine|July 10, 2020
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac deathJyh-Ming Jimmy Juang, Anna Binda, Shyh-Jye Lee, et al.
Brain : a Journal of Neurology|October 24, 2018
HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyondCarla Marini, Alessandro Porro, Agnès Rastetter, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Epilepsia|September 25, 2023
A novel de novo HCN2 loss-of-function variant causing developmental and epileptic encephalopathy treated with a ketogenic dietJacopo C DiFrancesco, Francesca Ragona, Carmen Murano, et al.
International Journal of Cardiology|June 17, 2018
APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe<sup>-/-</sup> atherosclerotic miceGabriele Romano, Serena Reggi, Barbara Kutryb-Zajac, et al.
Epilepsy Research|April 16, 2019
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literatureJacopo C DiFrancesco, Barbara Castellotti, Raffaella Milanesi, et al.
European Heart Journal|July 30, 2024
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implicationsAdriana Tarantino, Giuseppe Ciconte, Dario Melgari, et al.
European Heart Journal|November 22, 2020
Brugada syndrome genetics is associated with phenotype severityGiuseppe Ciconte, Michelle M Monasky, Vincenzo Santinelli, et al.
Ebiomedicine|July 10, 2020
GSTM3 variant is a novel genetic modifier in Brugada syndrome, a disease with risk of sudden cardiac deathJyh-Ming Jimmy Juang, Anna Binda, Shyh-Jye Lee, et al.
Brain : a Journal of Neurology|October 24, 2018
HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyondCarla Marini, Alessandro Porro, Agnès Rastetter, et al.
Pageof 7